Material Safety Data
Sheet
Salicylic Acid
ACC# 20315
|
Section 1 - Chemical Product and Company
Identification |
MSDS Name: Salicylic Acid
Catalog Numbers: S78056, S78056-1, A275, A275-12, A275-212,
A275-500, A275250LB, A277 500, A277-500, A277500, NC9747210, S780561,
SEA277100LB
Synonyms: Benzoic acid, 2-hydroxy-; o-Hydroxybenzoic
acid; 2-Hydroxybenzoic acid; Orthohydroxybenzoic acid
Company
Identification:
Fisher
Scientific
1 Reagent
Lane
Fair Lawn, NJ 07410
For information, call: 201-796-7100
Emergency Number:
201-796-7100
For CHEMTREC assistance, call: 800-424-9300
For
International CHEMTREC assistance, call: 703-527-3887
|
Section 2 -
Composition, Information on Ingredients |
| CAS# |
Chemical Name |
Percent |
EINECS/ELINCS |
| 69-72-7 |
Salicylic acid |
ca. 100 |
200-712-3 |
Hazard
Symbols: XN
Risk Phrases: 22 36/38
|
Section 3 - Hazards
Identification |
EMERGENCY OVERVIEW
Appearance: white. Warning! Contact with skin causes
irritation and possible burns, especially if the skin is wet or moist. Light
sensitive. Moisture sensitive. May be harmful if swallowed. May cause central
nervous system effects. Causes severe eye irritation. May cause reproductive and
fetal effects. Causes digestive and respiratory tract irritation.
Target Organs: Kidneys, central nervous system, pancreas.
Potential Health Effects
Eye: Causes severe eye irritation. May result in
corneal injury.
Skin: Contact with skin causes irritation
and possible burns, especially if the skin is wet or moist. If absorbed, may
cause symptoms similar to those for ingestion. May cause skin rash and
eruptions.
Ingestion: Causes gastrointestinal irritation
with nausea, vomiting and diarrhea. May cause "salicylism"; characterized by
headache, dizziness, ringing in the ears, hearing difficulty, visual
disturbances, mental confusion, drowsiness, sweating thirst, hyperventilation,
nausea, vomiting and diarrhea. May be harmful if swallowed. Severe salicylate
intoxication may cause central nervous system disturbances such as convulsions
and coma, skin eruptions, and alteration in the acid-base balance.
Inhalation: Causes irritation of the mucous membrane and
upper respiratory tract.
Chronic: May cause reproductive
and fetal effects. Laboratory experiments have resulted in mutagenic effects.
May cause salicylism with effects similar to those of skin absorption. May cause
damage to the kidneys and pancrease.
|
Section 4 - First Aid
Measures |
Eyes: Immediately flush eyes with plenty of water
for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get
medical aid immediately.
Skin: Get medical aid immediately.
Immediately flush skin with plenty of soap and water for at least 15 minutes
while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion: If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an unconscious person.
Get medical aid. Induce vomiting by giving one teaspoon of Syrup of Ipecac.
Inhalation: Get medical aid immediately. Remove from
exposure to fresh air immediately. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen.
Notes to
Physician: Follow with gastric lavage with activated charcoal. If
available, administer ferric hexacyanoferrate as a gastrointestinal trapping
agent. Persons with pre-existing skin disorders, eye problems, or impaired
kidney function may be more susceptible to the effects of this substance.
|
Section 5 - Fire
Fighting Measures |
General
Information: As in any fire, wear a self-contained breathing apparatus
in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective
gear. Dusts at sufficient concentrations can form explosive mixtures with air.
During a fire, irritating and highly toxic gases may be generated by thermal
decomposition or combustion.
Extinguishing Media: For small
fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam.
Water or foam may cause frothing. Use agent most appropriate to extinguish fire.
|
Section 6 -
Accidental Release Measures |
General
Information: Use proper personal protective equipment as indicated in
Section 8.
Spills/Leaks: Vacuum or sweep up material and
place into a suitable disposal container. Avoid generating dusty conditions.
Remove all sources of ignition. Provide ventilation.
|
Section 7 - Handling
and Storage |
Handling: Wash thoroughly after handling. Remove
contaminated clothing and wash before reuse. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid ingestion and inhalation.
Storage: Keep
away from sources of ignition. Do not store in direct sunlight. Store in a cool,
dry, well-ventilated area away from incompatible substances. Store protected
from moisture.
|
Section 8 - Exposure
Controls, Personal Protection |
Engineering
Controls: Facilities storing or utilizing this material should be
equipped with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the permissible
exposure limits.
Exposure Limits
| Chemical Name |
ACGIH |
NIOSH |
OSHA -
Final PELs |
| Salicylic acid |
none listed |
none listed |
none
listed |
OSHA Vacated PELs:
Salicylic acid: No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical safety goggles as described
by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin: Wear appropriate protective gloves to
prevent skin exposure.
Clothing: Wear appropriate
protective clothing to prevent skin exposure.
Respirators: A
respiratory protection program that meets OSHA's 29 CFR §1910.134 and ANSI Z88.2
requirements or European Standard EN 149 must be followed whenever workplace
conditions warrant a respirator's use.
|
Section 9 - Physical
and Chemical Properties |
Physical State:
Crystalline powder
Appearance: white
Odor: odorless -
slight phenolic odor
pH: 2.4
Vapor Pressure: 0.000082 mm
Hg
Vapor Density: No data
Evaporation Rate:Negligible
Viscosity: Not available.
Boiling Point: 211 deg C @
20.00mm Hg
Freezing/Melting Point:158 - 160 deg C
Autoignition
Temperature: 535 deg C ( 995.00 deg F)
Flash Point: 157 deg C (
314.60 deg F)
Decomposition Temperature:Not available.
NFPA
Rating: (estimated) Health: 0; Flammability: 1; Reactivity: 0
Explosion Limits, Lower:1.1 % @ 392F
Upper: Not available.
Solubility: Soluble.
Specific Gravity/Density:1.4400g/cm3
Molecular Formula:C7H6O3
Molecular Weight:138.12
|
Section 10 -
Stability and Reactivity |
Chemical
Stability: Stable under normal temperatures and pressures. Moisture
sensitive. Light sensitive. Darkens on exposure to light.
Conditions to
Avoid: High temperatures, incompatible materials, light, moisture, strong
oxidants.
Incompatibilities with Other Materials: Oxidizing agents,
lead acetate, iron salts, alkalis, iodine, spirit nitrous ether.
Hazardous Decomposition Products: Carbon monoxide, irritating and
toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Will
not occur.
|
Section 11 -
Toxicological Information |
RTECS#:
CAS# 69-72-7: VO0525000
LD50/LC50:
CAS#
69-72-7:
Draize test, rabbit, eye: 100 mg Severe;
Draize test, rabbit,
skin: 500 mg/24H Mild;
Inhalation, rat: LC50 = >900 mg/m3/1H;
Oral,
mouse: LD50 = 480 mg/kg;
Oral, rabbit: LD50 = 1300 mg/kg;
Oral, rat: LD50
= 891 mg/kg;
Skin, rabbit: LD50 = >10 gm/kg;
Skin, rat: LD50 = >2
gm/kg;
Carcinogenicity:
CAS# 69-72-7: Not listed by ACGIH,
IARC, NIOSH, NTP, or OSHA.
Epidemiology: No information available.
Teratogenicity: Oral, rat: TDLo = 1050 mg/kg (female 8-14 day(s)
after conception) Specific Developmental Abnormalities - Central Nervous System
and craniofacial (including nose and tongue) and musculoskeletal system.; Oral,
rat: TDLo = 350 mg/kg (female 8-14 day(s) after conception) Effects on Embryo or
Fetus - extra-embryonic structures (e.g., placenta, umbilical cord).; Oral,
mouse: TDLo = 1 gm/kg (female 17 day(s) after conception) Fertility -
post-implantation mortality (e.g. dead and/or resorbed implants per total number
of implants) and fetotoxicity (except death, e.g., stunted fetus).
Reproductive Effects: Oral, rat: TDLo = 1050 mg/kg (female 8-14
day(s) after conception) Maternal Effects - uterus, cervix, vagina and Fertility
- post-implantation mortality (e.g. dead and/or resorbed implants per total
number of implants) and litter size (e.g. # fetuses per litter; measured before
birth).; Oral, rat: TDLo = 40 mg/kg (female 20-21 day(s) after conception)
Maternal Effects - parturition.
Neurotoxicity: No information
available.
Mutagenicity: Mutation in Microorganisms: Saccharomyces
cerevisiae = 1 mmol/L/3H.; DNA Inhibition: Oral, mouse = 100 mg/kg.
Other
Studies: Standard Draize Test: Administration onto the skin (rabbit) = 500
mg/24Hr (Mild). Standard Draize Test: Administrat ion into the eye (rabbit) =
100 mg (Severe).
|
Section 12 -
Ecological Information |
Ecotoxicity:
Bacteria: Phytobacterium phosphoreum: EC50 = 214 mg/L; 5 min; Microtox test
Adsorption, volatilization and bioconcentration are not expected to be important
environmental fate processes. Biodegradation is expected to be the dominant
removal mechanism from soil and water. It may also undergo photochemical
degradation in sunlit environmental media.
Environmental: In air, it
is expected to exist in both the vapor and particulate phase. Vapor phase
reaction with photochemically produced hydroxyl radicals may be important
(estimated half-life of 1.2 days). Removal by wet and dry deposition can also
occur. BOD = 141%, 5 days.
Physical: Rapidly degrades to phenol when
heated.
Other: Dangerous to aquatic life in high concentrations.
|
Section 13 - Disposal
Considerations |
Chemical waste generators
must determine whether a discarded chemical is classified as a hazardous waste.
US EPA guidelines for the classification determination are listed in 40 CFR
Parts 261.3. Additionally, waste generators must consult state and local
hazardous waste regulations to ensure complete and accurate classification.
RCRA P-Series: None listed.
RCRA U-Series: None listed.
|
Section 14 -
Transport Information |
|
US
DOT |
IATA |
RID/ADR |
IMO |
Canada
TDG |
| Shipping Name: |
No information available. |
|
|
|
No information available. |
| Hazard Class: |
|
|
|
|
|
| UN Number: |
|
|
|
|
|
| Packing Group: |
|
|
|
|
|
|
Section 15 -
Regulatory Information |
US
FEDERAL
TSCA
CAS# 69-72-7 is listed on the TSCA
inventory.
Health & Safety Reporting List
None of the
chemicals are on the Health & Safety Reporting List.
Chemical Test
Rules
None of the chemicals in this product are under a Chemical Test
Rule.
Section 12b
None of the chemicals are listed under TSCA
Section 12b.
TSCA Significant New Use Rule
None of the chemicals
in this material have a SNUR under TSCA.
SARA
Section 302
(RQ)
None of the chemicals in this material have an RQ.
Section
302 (TPQ)
None of the chemicals in this product have a TPQ.
SARA
Codes
CAS # 69-72-7: acute, chronic.
Section 313
No
chemicals are reportable under Section 313.
Clean Air Act:
This
material does not contain any hazardous air pollutants. This material does not
contain any Class 1 Ozone depletors. This material does not contain any Class 2
Ozone depletors.
Clean Water Act:
None of the chemicals in this
product are listed as Hazardous Substances under the CWA. None of the chemicals
in this product are listed as Priority Pollutants under the CWA. None of the
chemicals in this product are listed as Toxic Pollutants under the CWA.
OSHA:
None of the chemicals in this product are considered highly
hazardous by OSHA.
STATE
CAS# 69-72-7 is not present on state
lists from CA, PA, MN, MA, FL, or NJ.
California No Significant Risk Level:
None of the chemicals in this product are listed. European/International
Regulations
European Labeling in Accordance with EC
Directives
Hazard Symbols:
XN
Risk Phrases:
R 22
Harmful if swallowed.
R 36/38 Irritating to eyes and skin.
Safety
Phrases:
S 26 In case of contact with eyes, rinse immediately
with
plenty of water and seek medical advice.
S 28 After contact with skin, wash
immediately
with...
S 39 Wear eye/face protection.
WGK (Water
Danger/Protection)
CAS# 69-72-7: 1
Canada
CAS# 69-72-7 is
listed on Canada's DSL List. CAS# 69-72-7 is listed on Canada's DSL List.
This product has a WHMIS classification of D2B.
CAS# 69-72-7 is listed
on Canada's Ingredient Disclosure List.
Exposure Limits
|
Section 16 -
Additional Information |
MSDS Creation Date:
6/10/1999
Revision #1 Date: 8/02/2000
The information above is
believed to be accurate and represents the best information currently available
to us. However, we make no warranty of merchantability or any other warranty,
express or implied, with respect to such information, and we assume no liability
resulting from its use. Users should make their own investigations to determine
the suitability of the information for their particular purposes. In no event
shall Fisher be liable for any claims, losses, or damages of any third party or
for lost profits or any special, indirect, incidental, consequential or
exemplary damages, howsoever arising, even if Fisher has been advised of the
possibility of such damages.